The Unknown Risks of Senolytics
Peptides like FOXO4-DRI & PNC-27 show promise for reducing senescent cells & preventing cancer. But are we experimenting too soon?
FOXO4-DRI may be a powerful senolytic, yet human data is lacking. Senescent cells play key signaling roles, so wiping them out completely might backfire—especially for younger users. The challenge? Finding the right dose, frequency & age to start.
With new senolytic products emerging, is it time to experiment or wait for more research?
Learn more about Peptides & Other Biohacking Protocols on episode 196 of the Mind Body Peak Performance Podcast
- For the full episode: https://youtu.be/A56xR6onhtQ
- Show notes: https://mindbodypeak.com/196
🔗 Links
- Music by Luke Hall: soundcloud.com/c_luke_hall
- Subscribe: https://mindbodypeak.com/subscribe
- Leave an Apple Podcast review: https://mindbodypeak.com/rate-podcast
